"EASE" Epicardial Access With the EpiAccess System (EASE2)
EASe 2- an Epicardial Access Study With the EpiAccess System- A Post-market Follow up Study.
研究概览
详细说明
Prior to enrolment, patients will be evaluated on the basis of the latest available data to establish eligibility. Eligible patients will be enrolled in the study by the local principal investigator after informed consent is obtained.
As EpiAccess is only used for the access portion of electrophysiology procedures, the safety, performance and effectiveness endpoints are acute from the time of needle insertion to pericardial space access (guidewire insertion into the pericardial sac). Patients will be followed until hospital discharge. Follow-up clinical examinations will be performed in accordance with institutions' standard of care. No special tests are required for this device. Patients' completion of study will occur at the time of their hospital discharge, or earlier if patient did not complete the study.
The stop criterion for this study is: greater than 25% Serious Adverse Device Effect, as defined in this protocol, after enrolment of 10 or more patients, compared to existing data from the literature presenting epicardial access procedure results during sub-xyphoid (minimally invasive) surgical procedures.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Prague、捷克共和国
- Nemocnice Na Homolka
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Patient is 18 years of age or older
- Pericardial access is clinically indicated
- Patient is willing and able to provide written informed consent
Exclusion Criteria:
- Patient with history of cardiac or pericardial surgery in the past 6 months
- Patient with history of chronic pericarditis
- Myocardial infarction within 4 weeks prior to procedure
- Class IV NYHA (New York Heart Association) heart failure symptoms
- Cerebrovascular accident within previous 6 months
- Known carotid artery stenosis greater than 80%
- Presence of thrombus in the left atrium
- Coagulopathy
- Severe Hepatic Dysfunction or Enlargement
- Life expectancy less than 6 months
- BMI > 40
- Patient is enrolled in another clinical trial
- Patient is pregnant
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
其他:EpiAccess
EpiAccess will be used to gain access to the normal, non-distended pericardial space in subjects presenting with the need for pericardial access as determined by the patient's physician.
|
Access to the pericardium to enable further treatments.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Percentage of Participants in Whom Pericardial Access Was Achieved With the EpiAccess System
大体时间:Through discharge / approx 4 days
|
EpiAccess device shall be used to access the pericardial space with measurements tracked noting if access was achieved.
The percentage of patients in whom pericardial access was successful will be reported.
|
Through discharge / approx 4 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Percentage of Participants in Whom Equivalent or Better Access Was Achieved With EpiAccess System
大体时间:access through procedure completion
|
EpiAccess will provide equivalent or better access (defined as guidewire entry into the pericardial space) as compared to access with standard of care minimally invasive, subxiphoid access techniques.
|
access through procedure completion
|
Percentage of Participants With a Pericardial Effusion of >80ml
大体时间:Access through discharge/approximately 4 days
|
Secondary endpoint will measure whether or not there was a pericardial effusion greater than 80ml.
|
Access through discharge/approximately 4 days
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Number of Patients in Whom Pericardial Access Was Achieved With the EpiAccess System
大体时间:Access through end of procedure
|
Number of patients in whom the EpiAccess system was equivalently able to access the pericardial space, compared with standard of care minimally invasive access techniques,documented by using intra procedure or post procedure clinician survey
|
Access through end of procedure
|
合作者和调查者
赞助
调查人员
- 首席研究员:Andrea Natale, MD、University of Debrecen, Cardiology/Electrophysiology Department; Debrecen, Hungary
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
心律失常,心脏的临床试验
Pericardial access的临床试验
-
Aalborg University Hospital完全的脊柱侧弯 | 脊柱后凸 | 神经外科 | 麻醉后体温过低 | 强制空气加热 | 主要脊柱融合术
-
Beckman Coulter, Inc.尚未招聘
-
University of North Carolina, GreensboroInstitute of Education Sciences完全的注意力缺陷多动障碍
-
Hanyang University Seoul HospitalSeegene Medical Foundation完全的